Advertisement

Topics

China's Innovative Medical cancels Pluristem investment

03:25 EDT 22 Jun 2017 | Globes

Pluristem blamed Chinese foreign current regulations, but the Chinese company said it was dissatisfied with the results of due diligence.

Original Article: China's Innovative Medical cancels Pluristem investment

NEXT ARTICLE

More From BioPortfolio on "China's Innovative Medical cancels Pluristem investment"

Advertisement
Quick Search
Advertisement
Advertisement